首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Synthesis and in vitro microbiological evaluation of novel diethyl 6,6′-(1,4-phenylene) bis (4-aryl-2-oxo-cyclohex-3-enecarboxylates)
【24h】

Synthesis and in vitro microbiological evaluation of novel diethyl 6,6′-(1,4-phenylene) bis (4-aryl-2-oxo-cyclohex-3-enecarboxylates)

机译:新型6,6'-(1,4-亚苯基)二乙基双(4-芳基-2-氧代-环己基-3-烯基羧酸酯)的合成及体外微生物学评价

获取原文
       

摘要

Novel bis cyclohexenone ester derivatives 14–19 were synthesized and characterized by their spectral data. In vitro microbiological evaluations were carried out for all the novel compounds 14–19 against clinically isolated bacterial and fungal strains. Compounds 15, 16, 18 against Staphylococcus aureus, 14, 15 against β-Haemolytic streptococcus, 15, 19 against Micrococcus luteus, 17, 18 against Salmonella typhii, 14, 17 against Shigella flexneri, 15 against Escherichia coli, 16 against Pseudomonas aeruginosa, 15, 18, 19 against Klebsiella pneumonia exhibited potent antibacterial activity at an minimum inhibitory concentration (MIC) value of 6.25 μg/ml, whereas compound 16 against Aspergillus flavus, 17 against A. niger, 16, 18 against Mucor indicus, 15, 17–19 against Microsporum gypseum revealed excellent antifungal activity at an MIC value of 6.25 μg/ml.
机译:合成了新型双环己烯酮酯衍生物14-19,并通过其光谱数据对其进行了表征。对所有新化合物14-19对临床分离的细菌和真菌菌株进行了体外微生物学评估。化合物15、16、18对抗金黄色葡萄球菌,14、15对抗β-溶血性链球菌,15、19对抗黄褐球菌,17、18对抗伤寒沙门氏菌,14、17对抗弗氏志贺氏菌,15对抗大肠杆菌,16对抗铜绿假单胞菌,在最小抑菌浓度(MIC)值为6.25μg/ ml的情况下,针对肺炎克雷伯菌的15、18、19表现出有效的抗菌活性,而针对黄曲霉的化合物16,针对黑曲霉的17,针对18的Mucor indicus,15、17的化合物16对抗小孢子石膏的–19具有优异的抗真菌活性,MIC值为6.25μg/ ml。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号